EU Regulatory Roundup, October 2019: A Month Characterized By Delay, Uncertainty And Shock
Executive Summary
The impending reality of the EU MDR and IVDR is spurring increased activity at European Commission level. But some of this activity is wrong-footing other stakeholders, who must be nimble, flexible and resilient to cope with any sudden changes.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.